Biotangents
PrivateLast Round
Series A
Nov 28, 2024
Total Funding Raised
$9.22M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Biotangents is a biotechnology company that develops veterinary diagnostic devices designed to detect infectious diseases in livestock.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biotangents Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Biotangents Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 28, 2024 | ||||
| Debt | May 18, 2022 | ||||
| Early Funding | May 18, 2022 | ||||
| Early Funding | Aug 1, 2021 | ||||
| Early Funding | May 6, 2019 |
Key People
Founding team and executive leadership
Biotangents Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Debt |
| Eos Advisory | Series A |
| Scottish Investment Bank (Scottish Enterprise) | Early Funding, Grant, Seed, Series A |
| Kelvin Capital | Grant, Seed, Series A, Early Funding |
| British Business Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Monthly visitors grew 37% MoM, reaching 903.
- Jul 6, 2025
Monthly visitors increased 32% MoM.
Biotangents Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Biotangents's valuation, stock price, and market status.